Next Article in Journal
Vaccination Against RhoC in Prostate Cancer Patients Induces Potent and Long-Lasting CD4+ T Cell Responses with Cytolytic Potential in the Absence of Clinical Efficacy: A Randomized Phase II Trial
Next Article in Special Issue
Next-Generation Vaccine Platforms: Integrating Synthetic Biology, Nanotechnology, and Systems Immunology for Improved Immunogenicity
Previous Article in Journal
Routine Immunisation Coverage Shows Signs of Recovery at Global Level Postpandemic, but Important Declines Persist in About 20% of Countries
Previous Article in Special Issue
Beyond Vaccination: Exploring Young Adults’ Awareness, Knowledge, and Attitudes Related to Sexually Transmitted Infections in Romania
 
 
Review

Article Versions Notes

Vaccines 2025, 13(4), 389; https://doi.org/10.3390/vaccines13040389
Action Date Notes Link
article xml file uploaded 4 April 2025 07:59 CEST Original file -
article xml uploaded. 4 April 2025 07:59 CEST Update https://www.mdpi.com/2076-393X/13/4/389/xml
article pdf uploaded. 4 April 2025 07:59 CEST Version of Record https://www.mdpi.com/2076-393X/13/4/389/pdf
article html file updated 4 April 2025 08:01 CEST Original file https://www.mdpi.com/2076-393X/13/4/389/html
Back to TopTop